rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2007-10-17
|
pubmed:abstractText |
An alternative to currently marketed topical minoxidil solutions is desirable.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1097-6787
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
57
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
767-74
|
pubmed:meshHeading |
pubmed-meshheading:17761356-Administration, Topical,
pubmed-meshheading:17761356-Adult,
pubmed-meshheading:17761356-Alopecia,
pubmed-meshheading:17761356-Double-Blind Method,
pubmed-meshheading:17761356-Hair,
pubmed-meshheading:17761356-Humans,
pubmed-meshheading:17761356-Male,
pubmed-meshheading:17761356-Middle Aged,
pubmed-meshheading:17761356-Minoxidil,
pubmed-meshheading:17761356-Questionnaires,
pubmed-meshheading:17761356-Time Factors,
pubmed-meshheading:17761356-Treatment Outcome
|
pubmed:year |
2007
|
pubmed:articleTitle |
A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.
|
pubmed:affiliation |
Duke University Medical Center, Durham, North Carolina 27516, USA. olsen001@mc.duke.edu
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|